Legend Biotech (LEGN) Interest & Investment Income (2020 - 2025)
Legend Biotech (LEGN) posted Interest & Investment Income of $7.9 million for Q4 2025, down 18.23% on a QoQ basis from $9.7 million in Q3 2025, and down 42.34% year-over-year from $13.7 million in Q4 2024.
Legend Biotech (LEGN) has 6 years of Interest & Investment Income data on file, last reported at $7.9 million in Q4 2025.
- In Q4 2025, Interest & Investment Income fell 42.34% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $40.0 million (down 34.61% YoY), while the FY2025 annual figure was $40.1 million, down 34.48% from the prior year.
- Interest & Investment Income retreated to $7.9 million in Q4 2025, from $9.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $17.0 million in Q2 2024 and bottomed at -$18.4 million in Q3 2023.
- A 5-year average of $2.7 million and a median of -$127000.0 in 2021 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income sank 1374.89% — and 2024, when it jumped 305.33%.
- Year by year, Interest & Investment Income stood at -$971000.0 in 2021, then sank by 742.64% to -$8.2 million in 2022, then tumbled by 125.13% to -$18.4 million in 2023, then jumped by 174.38% to $13.7 million in 2024, then plunged by 42.34% to $7.9 million in 2025.
- The last three Interest & Investment Income figures came in at $7.9 million (Q4 2025), $9.7 million (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 19.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.90 Mn |
| Sep 30, 2025 | 9.66 Mn |
| Jun 30, 2025 | 10.43 Mn |
| Mar 31, 2025 | -12.06 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 16.63 Mn |
| Jun 30, 2024 | 17.05 Mn |
| Mar 31, 2024 | 13.87 Mn |
| Sep 30, 2023 | -18.42 Mn |
| Jun 30, 2023 | -12.01 Mn |
| Mar 31, 2023 | -6.76 Mn |
| Dec 31, 2022 | -8.18 Mn |
| Sep 30, 2022 | -1.51 Mn |
| Jun 30, 2022 | -1.33 Mn |
| Mar 31, 2022 | -458,000.00 |
| Dec 31, 2021 | -971,000.00 |
| Sep 30, 2021 | -321,000.00 |
| Jun 30, 2021 | -127,000.00 |
| Mar 31, 2021 | -100,000.00 |
| Dec 31, 2020 | -2.93 Mn |
| Sep 30, 2020 | -804,000.00 |